Net Deals Web Search

Search results

1. ALC - Alcon Inc.

   Yahoo Finance

   • News
   •  Charts
   •  Conversations

   • Range :
   • 1d
   • 5d
   • 6m
   • 1y
   • Max

   89.43-0.33 (-0.37%)

   at Fri, May 24, 2024, 4:00PM EDT - U.S. markets closed

   Delayed Quote

   • Open 89.66
   • High 89.97
   • Low 89.34
   • Prev. Close 89.76

   • 52 Wk. High 91.08
   • 52 Wk. Low 69.44
   • P/E 42.38
   • Mkt. Cap 44.24B

   • NYSE
   • •Price in USD

2. Results From The WOW.Com Content Network

3. Alcon - Wikipedia

   en.wikipedia.org/wiki/Alcon

   Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

4. Gilead Sciences - Wikipedia

   en.wikipedia.org/wiki/Gilead_Sciences

   Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.

5. Aerie Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Aerie_Pharmaceuticals

   Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...

6. Alcon Laboratories is considering a major $100M expansion of ...

   www.aol.com/alcon-laboratories-considering-major...

   Alcon’s most recent earnings report projects close to $9.5 billion in net sales in 2023. Alcon Laboratories in Fort Worth employs about 4,500 people, ...

7. Alcon (ALC) Launches Preservative-Free Drops for Dry Eye Relief

   www.aol.com/news/alcon-alc-launches-preservative...

   Alcon's (ALC) new preservative-free solution for patients with dry eye symptoms is the latest addition to its leading global artificial tear brand Systane.

8. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

   www.aol.com/2010/08/26/novartis-alcon-buy...

   The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.